About TRANSIA
Transia GmbH Industriediagnostica was founded in 1988. The companies mission is to provide modern, cost effective and time saving analytical methods to the food and feed industry to improve the consumer´s safety.
The active program spans a wide range of immunological systems (ELISAs) for the detection of toxins, pesticides, antibiotics, hormones, proteins (including allergens) and pathogens. The customer friendly kits are used in industrial or service laboratories to assure the quality of food products. They are also used in governmental laboratories to control current legislation.
Besides the immunological methods we offer other "rapid methods" to determine bacterial contamination in food. To control cleaning and hygiene different methods are provided: ranging from a direct protein detection (Easy Check), a surface contact slides (Hygiene monitor) to ATP Measurement.
As independent company Transia GmbH cooperates exclusively with international manufacturers and impacts development and applications.
We also include the job market in our future-orinetated actions. All employed clerks have been educated in our company.
- Focus : Manufacturer
- Employees: 11-50
- Industry : Diagnostics
Product portfolio of TRANSIA
Similar companies
Here you will find TRANSIA GmbH
See the theme worlds for related content
Topic world Diagnostics
Diagnostics is at the heart of modern medicine and forms a crucial interface between research and patient care in the biotech and pharmaceutical industries. It not only enables early detection and monitoring of disease, but also plays a central role in individualized medicine by enabling targeted therapies based on an individual's genetic and molecular signature.
Topic world Diagnostics
Diagnostics is at the heart of modern medicine and forms a crucial interface between research and patient care in the biotech and pharmaceutical industries. It not only enables early detection and monitoring of disease, but also plays a central role in individualized medicine by enabling targeted therapies based on an individual's genetic and molecular signature.
